Cuur Diagnostics

ANTIMICROBIAL RESISTANCE:

A Global Crisis

80 Years of Antibiotic Overuse
A Global Crisis

The discovery of antibiotics was heralded as one of the greatest medical discoveries in modern history and the drugs quickly became the cornerstone of modern medicine.  Antibiotics made life saving surgery, chemotherapy, organ transplants and care of premature infants possible.

Yet after 80 years of significant overuse in human medicine and agriculture, antibiotics are losing their effectiveness. It is estimated that up to 50% of all prescribed antibiotics are either not needed—such as antibiotics given to treat viral infections—or are not properly “matched” to the bacteria they’ve been prescribed to treat, and therefore are not as effective as they could be. 

T H E  R I S K

Antimicrobial Resistance has led to a sharp increase in drug-resistant infections around the world. As a result, antibiotic resistance is now one of the greatest public health threats of our time, with substantial impacts on people, health care systems and economies worldwide. Without urgent action, it is estimated that by 2050, 10 million people a year will die from drug-resistant infections and $100 trillion in global economic productivity will have been lost over that time period.

Every Year in the United States Alone (CDC)
  • Over 2,000,000 Antimicrobial-Resistant Infections
  • At Least 23,000 Deaths Every Year
  • At least 30% of antibiotics prescribed in the US doctor’s offices and Emergency Departments are unnecessary
  • Antimicrobial Resistance Disproportionately Affects Our Children and Elderly
T H E  C O S T
The threat of Antimicrobial Resistance not only poses a colossal threat to global health but also incurs significant economic costs to society. Economic evaluations of antimicrobials and interventions that affect their consumption rarely include what Antimicrobial Resistance costs yet will significantly impact our future and cannot be ignored.
Infectious Disease Care
Infectious Disease Care

D I A G N O S T I C S

The CUUR Diagnostics Solution

Despite dramatic advances in diagnostic technologies, patients with suspected infections receive inadequate antimicrobial treatment. The result is overuse of our limited inventory of effective antimicrobials and those numbers continue to dwindle due to increasing levels of antimicrobial resistance. Real people like our grandparents, parents, children, neighbors, and friends are the reason together we must address the problem of antimicrobial resistance.

Discover how CUUR Diagnostics molecular testing solutions can help diminish some of the world’s greatest healthcare challenges – including yours.

CUUR Diagnostics offers a critical link in the physician’s response to an infected patient and one that is sometimes overlooked in stewardship discussions and models. Rapid diagnostics for distinguishing between viral and bacterial infections greatly facilitate the decision of whether or not to prescribe which antibiotics. CUUR Diagnostics’ proprietary solutions bring much-needed products and services to aid physicians in the arenas of bedside, clinic and field diagnosis by rapidly matching disease agents with appropriate therapies.